Skip to main content
. 2023 Jun 20;16(6):906. doi: 10.3390/ph16060906

Figure 7.

Figure 7

Schematic representation of the effect of cyclic C-VGB3 on VEGFR2 downstream signaling pathways. C-VGB3 recognizes the extracellular domain of VEGFR2 and inhibits its activation (phosphorylation) and downstream signaling pathways in endothelial and/or MCT cells.